These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1832900)

  • 1. Fotemustine with or without dacarbazine for brain metastases of malignant melanoma.
    Merimsky O; Inbar M; Reider-Groswasser I; Chaitchik S
    Eur J Cancer; 1991; 27(8):1066. PubMed ID: 1832900
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acquired myelodysplastic syndromes after treatment of melanoma with fotemustine and dacarbazine].
    Perrot JL; Lanthier K; Benoit F; Graille MC; Guy C; Bertheas MF; Cambazard F
    Ann Dermatol Venereol; 1995; 122(10):663-6. PubMed ID: 8687048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
    Avril MF; Aamdal S; Grob JJ; Hauschild A; Mohr P; Bonerandi JJ; Weichenthal M; Neuber K; Bieber T; Gilde K; Guillem Porta V; Fra J; Bonneterre J; Saïag P; Kamanabrou D; Pehamberger H; Sufliarsky J; Gonzalez Larriba JL; Scherrer A; Menu Y
    J Clin Oncol; 2004 Mar; 22(6):1118-25. PubMed ID: 15020614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of cerebral metastases from malignant melanoma: results of a combined, simultaneous treatment with fotemustine and irradiation.
    Ulrich J; Gademann G; Gollnick H
    J Neurooncol; 1999 Jun; 43(2):173-8. PubMed ID: 10533730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathol Biol (Paris); 1990 Oct; 38(8):876-80. PubMed ID: 2274396
    [No Abstract]   [Full Text] [Related]  

  • 6. Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma.
    Calabresi F; Aapro M; Becquart D; Dirix L; Wils J; Ardizzoni A; Gerard B
    Ann Oncol; 1991 May; 2(5):377-8. PubMed ID: 1954183
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma.
    Jacquillat C; Khayat D; Banzet P; Weil M; Avril MF; Fumoleau P; Namer M; Bonneterre J; Kerbrat P; Bonerandi JJ
    Cancer Chemother Pharmacol; 1990; 25(4):263-6. PubMed ID: 2403853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of a new nitrosourea compound: fotemustine].
    Boaziz C
    Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):964-8. PubMed ID: 1338920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological toxicity during metastatic melanoma treatment with fotemustine.
    Khalil Z; Pageot N; Carlander B; Guillot B
    Melanoma Res; 2005 Dec; 15(6):563-4. PubMed ID: 16314745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective combined immunochemotherapy with dinitrochlorobenzene and fotemustine in skin and brain metastases of melanoma.
    Göring HD; Zierner A; Kröning Y; Trebing D; Kämpgen E; Bröcker EB
    Melanoma Res; 1998 Aug; 8(4):379. PubMed ID: 9764815
    [No Abstract]   [Full Text] [Related]  

  • 11. Final report of the French multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases.
    Jacquillat C; Khayat D; Banzet P; Weil M; Fumoleau P; Avril MF; Namer M; Bonneterre J; Kerbrat P; Bonerandi JJ
    Cancer; 1990 Nov; 66(9):1873-8. PubMed ID: 2224783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fotemustine in the treatment of brain primary tumors and metastases.
    Khayat D; Giroux B; Berille J; Cour V; Gerard B; Sarkany M; Bertrand P; Bizzari JP
    Cancer Invest; 1994; 12(4):414-20. PubMed ID: 8032964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: report on a pilot study.
    Bröcker EB; Bohndorf W; Kämpgen E; Trcka J; Messer P; Tilgen W; Engenhart K; Flentje M
    Melanoma Res; 1996 Oct; 6(5):399-401. PubMed ID: 8908601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fotemustine--an advance in the treatment of metastatic malignant melanoma.
    Merimsky O; Inbar M; Gerard B; Chaitchik S
    Melanoma Res; 1992 Dec; 2(5-6):401-6. PubMed ID: 1292787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
    Célérier P; Dreno B; Bureau B; Litoux P
    Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma].
    Mornex F; Thomas L; Mohr P; Hauschild A; Delaunay MM; Lesimple T; Tilgen W; Nguyen BB; Guillot B; Ulrich J; Bourdin S; Mousseau M; Cupissol D; Bonneterre J; de Gislain C; Bensadoun JR; Clavel M
    Cancer Radiother; 2003 Feb; 7(1):1-8. PubMed ID: 12648711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive phase II study in the treatment of advanced malignant melanoma with fotemustine.
    Schallreuter KU; Wenzel E; Brassow FW; Berger J; Breitbart EW; Teichmann W
    Cancer Chemother Pharmacol; 1991; 29(1):85-7. PubMed ID: 1742855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fotemustine for the treatment of melanoma.
    Quéreux G; Dréno B
    Expert Opin Pharmacother; 2011 Dec; 12(18):2891-904. PubMed ID: 22077794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study.
    Khayat D; Cour V; Bizzari JP; Aigner K; Borel C; Cohen-Alloro G; Weil M; Auclerc G; Buthiau D; Bousquet JC
    Am J Clin Oncol; 1991 Oct; 14(5):400-4. PubMed ID: 1951178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brain metastases of malignant melanomas].
    Boaziz C; Breau JL; Morere JF; Israël L
    Bull Cancer; 1991; 78(4):347-53. PubMed ID: 1859902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.